Early Application of Continuous Renal Replacement Therapy as Adjunctive Support in Pediatric Septic Shock: A Prospective Observational Study
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 50
- 试验地点
- 1
- 主要终点
- Time to shock reversal
研究概览
简要总结
Septic shock is a major cause of morbidity and mortality in critically ill children. Continuous renal replacement therapy (CRRT) is increasingly used as adjunctive support in pediatric septic shock to improve hemodynamic stability, modulate inflammatory responses, and correct metabolic disturbances. However, evidence regarding optimal indications, timing, and clinical outcomes of early CRRT use in children remains limited.
This prospective observational study aims to evaluate associations between early CRRT use and changes in hemodynamics, organ dysfunction, inflammatory cytokine levels, and short-term clinical outcomes in pediatric patients with septic shock admitted to pediatric intensive care units
详细描述
This is a prospective observational cohort study conducted in pediatric intensive care units (PICUs). Children diagnosed with septic shock who receive early continuous renal replacement therapy (CRRT) as part of routine clinical care will be consecutively enrolled.
Baseline assessments will be performed prior to CRRT initiation and include clinical status, hemodynamic parameters, echocardiographic indices, laboratory markers, and inflammatory cytokine levels. Follow-up assessments will be conducted at predefined time points after CRRT initiation.
CRRT initiation, modality, and management will follow institutional protocols and treating physician judgment. No randomization or intervention assignment is performed. Patients will be followed during PICU stay and up to Day 28 after PICU admission
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 1 Month 至 17 Years（Child）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Age from 1 month to <18 years
- •Diagnosis of septic shock according to Phoenix Sepsis Criteria, defined as:
- •Phoenix Sepsis Score ≥ 2, and
- •Presence of circulatory dysfunction
- •Fulfillment of at least one of the following:
- •Acute kidney injury KDIGO stage 2 or higher
- •Requirement for vasoactive support with Vasoactive-Inotropic Score (VIS) ≥ 50
- •Admission to a Pediatric Intensive Care Unit (PICU)
- •Written informed consent obtained from parent(s) or legal guardian(s)
排除标准
- •Expected survival <24 hours at time of screening
- •o End-stage organ failure, including: End-stage renal disease requiring chronic dialysis or eGFR <15 mL/min/1.73 m²
- •End-stage liver disease
- •End-stage heart failure
- •Known immunosuppression, including HIV infection or primary immunodeficiency disorders
- •Emergency indications for CRRT unrelated to septic shock (e.g., severe hyperkalemia, severe dysnatremia, symptomatic uremia, or fluid overload >10%)
- •PICU length of stay <24 hours
- •CRRT duration <6 hours
结局指标
主要结局
Time to shock reversal
时间窗: From initiation of CRRT until first documented shock reversal, assessed up to 7 days after CRRT initiation during PICU stay
Shock reversal is defined as sustained improvement in hemodynamic stability, including reduction of vasoactive support, normalization of age-adjusted heart rate and blood pressure, arterial lactate \<2 mmol/L, and central venous oxygen saturation (ScvO₂) between 70-75%.
Change in Pediatric Sequential Organ Failure Assessment (pSOFA) Score
时间窗: Baseline, 24 hours, 48 hours, 72 hours, Day 5, and Day 7 after CRRT initiation
Change in organ dysfunction severity assessed using the Pediatric Sequential Organ Failure Assessment (pSOFA) score (range: 0-24), with higher scores indicating more severe organ dysfunction
次要结局
- Change in mean arterial pressure (MAP)(Time Frame: Baseline, 6 hours, 12 hours, 24 hours, 48 hours, and 72 hours after CRRT initiation)
- Change in serum cytokine levels(Baseline, 12 hours, 24 hours, and 48 hours after CRRT initiation)
- Changes in serum lactate concentration(Baseline, 6 hours, 12 hours, 24 hours, 48 hours, and 72 hours after CRRT initiation)
- Mortality outcomes(up to day 28)
研究者
Phuc Huu Phan
Principle Investigator
National Children's Hospital, Vietnam